COVID-19 pericarditis mimicking an acute myocardial infarction: a case report and review of literature

References

• https://www.who.int/csr/don/05-january-2020-pneumonia-of-unkown-cause-china/en/Accessed April 28, 2020
   Google Scholar
• Sohrabi C, Alsafi Z, O’Neill N, et al. World health organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020, 71-76. doi:10.1016/j.ijsu.2020.02.034.
   Web of Science ®Google Scholar
• https://coronavirus.jhu.edu/Accessed April 30, 2020
   Google Scholar
• Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513.
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062.
   Web of Science ®Google Scholar
• Ruan Q, Yang K, Wang W, et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan. China: Intensive care medicine; 2020. p. 1–3.
   Google Scholar
• Klok F, Kruip M, Van Der Meer N, et al., Incidence of thrombotic complications in critically ill ICU patients with COVID-19, Thrombosis Research (2020).
   Google Scholar
• Shao F, Xu S, Ma X, et al., In-hospital cardiac arrest outcomes among patients with COVID-19 pneumonia in Wuhan, China, Resuscitation 151 (2020) 18–23.
   Google Scholar
• Long B, Brady WJ, Koyfman A, et al. Cardiovascular complications in COVID-19. Am J Emerg Med. 2020;38(7):1504–1507.
   Web of Science ®Google Scholar
• Aghagoli G, Gallo Marin B, Soliman LB, et al. Cardiac involvement in COVID-19 patients: risk factors, predictors, and complications: a review. J Card Surg. 2020;35(6):1302–1305.
   Web of Science ®Google Scholar
• Nguyen JL, Yang W, Ito K, et al. Seasonal influenza infections and cardiovascular disease mortality. JAMA Cardiol. 2016;1(3):274–281.
   PubMed Web of Science ®Google Scholar
• Hilgenfeld R, Peiris M. From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses. Antiviral Res. 2013;100(1):286–295.
   PubMed Web of Science ®Google Scholar
• Xiong T-Y, Redwood S, Prendergast B, et al. Coronaviruses and the cardiovascular system: acute and long-term implications. Eur Heart J. 2020;41(19):1798–1800.
   Web of Science ®Google Scholar
• Chen L, Li X, Chen M, et al. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res. 2020;116(6):1097–1100.
   PubMed Web of Science ®Google Scholar
• Zhang H, Penninger JM, Li Y, et al. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46(4):586–590.
   PubMed Web of Science ®Google Scholar
• Dong N, Cai J, Zhou Y, et al. End-stage heart failure with COVID-19: strong evidence of myocardial injury by 2019-nCoV. JACC Heart Fail. 2020;8(6):515-517. doi10.1016/j.jchf.2020.04.001.
   Web of Science ®Google Scholar
• Deng Q, Hu B, Zhang Y, et al. Suspected myocardial injury in patients with COVID-19: evidence from front-line clinical observation in Wuhan, China. Int J Cardiol. 2020;311:116–121.
   Web of Science ®Google Scholar
• Han H, Xie L, Liu R, et al. Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan, China. J Med Virol. 2020;92(7):819–823.
   Web of Science ®Google Scholar
• Li JW, Han TW, Woodward M, et al. The impact of 2019 novel coronavirus on heart injury: a systemic review and meta-analysis. Prog Cardiovasc Dis. 2020;63(4):518–524.
   Web of Science ®Google Scholar
• Fung G, Luo H, Qiu Y, et al. Myocarditis. Circ Res. 2016;118(3):496–514.
   PubMed Web of Science ®Google Scholar
• Pollack A, Kontorovich AR, Fuster V, et al. Viral myocarditis–diagnosis, treatment options, and current controversies. Nat Rev Cardiol. 2015;12(11):670–680.
   PubMed Web of Science ®Google Scholar
• Hua A, O’Gallagher K, Sado D, et al. Life-threatening cardiac tamponade complicating myo-pericarditis in COVID-19. Eur Heart J. 2020;41(22):2130. doi:10.1093/eurheartj/ehaa253.
   Web of Science ®Google Scholar
• Siddamreddy S, Thotakura R, Dandu V, et al. Corona virus disease 2019 (COVID-19) presenting as acute ST elevation myocardial infarction. Cureus. 2020;12(4):e7782.
   PubMed Web of Science ®Google Scholar
• Dabbagh MF, Aurora L, D’Souza P, et al. Cardiac Tamponade Secondary to COVID-19. JACC Case Rep. 2020;2(9):1326–1330.
   Google Scholar
• Irabien-Ortiz A, Carreras-Mora J, Sionis A, et al. Fulminant myocarditis due to COVID-19. Rev Esp Cardiol (Engl Ed. 2020;73(6):503-504. doi:10.1016/j.rec.2020.04.005.
   Web of Science ®Google Scholar
• Azarkish M, Laleh Far V, Eslami M, et al. Transient complete heart block in a patient with critical COVID-19. Eur Heart J. 2020;41(22):2131.
   Web of Science ®Google Scholar
• Mahmud E, Dauerman HL, Welt FG, et al. Management of acute myocardial infarction during the COVID-19 pandemic. J Am Coll Cardiol. 2020;76(11):1375–1384.
   Web of Science ®Google Scholar
• Tavazzi G, Pellegrini C, Maurelli M, et al. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail. 2020;22(5):911–915.
   Web of Science ®Google Scholar
• Meyer P, Degrauwe S, Delden CV, et al. Typical takotsubo syndrome triggered by SARS-CoV-2 infection. Eur Heart J. 2020;41(19):1860.
   Web of Science ®Google Scholar
• Kim IC, Kim JY, Kim HA, et al. COVID-19-related myocarditis in a 21-year-old female patient. Eur Heart J. 2020;41(19):1859. doi:10.1093/eurheartj/ehaa288.
   Web of Science ®Google Scholar
• Zeng JH, Liu YX, Yuan J, et al. First case of COVID-19 complicated with fulminant myocarditis: a case report and insights. Infection. 2020;48(5):773–777.
   Web of Science ®Google Scholar
• Sala S, Peretto G, Gramegna M, et al. Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection. Eur Heart J. 2020;41(19):1861–1862.
   Web of Science ®Google Scholar
• Inciardi RM, Lupi L, Zaccone G, et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):819-824. doi:10.1001/jamacardio.2020.1096.
   PubMed Web of Science ®Google Scholar
• Hu H, Ma F, Wei X, et al. Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin. Eur Heart J. 2020;42(2):206. doi: 10.1093/eurheartj/ehaa190.
   Web of Science ®Google Scholar
• Loghin C, Chauhan S, Lawless SM. Pseudo acute myocardial infarction in a young COVID-19 patient. JACC Case Rep. 2020;15;2(9):1284-1288. doi:10.1016/j.jaccas.2020.04.015.
   Google Scholar
• Vidovich MI. Transient brugada-like ECG pattern in a patient with coronavirus disease 2019 (COVID-19). JACC Case Rep. 2020;15;2(9):1245-1249. doi:10.1016/j.jaccas.2020.04.007.
   Google Scholar
• He J, Wu B, Chen Y, et al. Characteristic electrocardiographic manifestations in patients with COVID-19. Can J Cardiol. 2020;36(6):966.e1-966.e4.
   Web of Science ®Google Scholar
• Bemtgen X, Kruger K, Supady A, et al. First successful treatment of COVID-19 induced refractory cardiogenic plus vasoplegic shock by combination of pVAD and ECMO - a case report. Asaio J. 2020;66(6):607-609. doi: 10.1097/MAT.0000000000001178.
   Web of Science ®Google Scholar
• Paul JF, Charles P, Richaud C, et al. Myocarditis revealing COVID-19 infection in a young patient. Eur Heart J Cardiovasc Imaging. 2020;21(7):776.
   Web of Science ®Google Scholar
• Sulemane S, Baltabaeva A, Barron AJ, et al. Acute pulmonary embolism in conjunction with intramural right ventricular thrombus in a SARS-CoV-2-positive patient. Eur Heart J Cardiovasc Imaging. 2020;21(9):1054.
   Web of Science ®Google Scholar